The National Institutes of Health (NIH) has announced a grant opportunity, designated as PAR-23-311, aimed at Small Business Concerns (SBCs) in the field of neurosciences and neurological disorders. This funding opportunity is an initiative of the National Institute of Neurological Disorders and Stroke (NINDS) and seeks to support exploratory clinical trials that align with the institute’s mission and goals. The focus is on fostering innovative research in the development and evaluation of drugs, biologics, devices, diagnostics, and various therapies, including surgical, behavioral, and rehabilitation therapies.
Eligibility for this grant is specifically directed towards small businesses, emphasizing the NIH’s commitment to advancing scientific discoveries and innovations in the field of neurosciences through the Small Business Innovation Research (SBIR) program. This opportunity supports only SBIR Phase II and Fast-Track applications, providing a unique platform for small businesses to contribute to significant advancements in the understanding and treatment of neurological disorders. The closing date for applications is set for September 5, 2026, offering an extended period for interested small businesses to prepare and submit their proposals. This initiative represents an important step in encouraging small business participation in cutting-edge neurological research and development, potentially leading to breakthroughs in the treatment and management of various neurological conditions.
Opportunity ID: 351149
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-23-311 |
| Funding Opportunity Title: | NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | |
| Expected Number of Awards: | |
| CFDA Number(s): | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 27, 2023 |
| Last Updated Date: | Nov 27, 2023 |
| Original Closing Date for Applications: | Sep 05, 2026 |
| Current Closing Date for Applications: | Sep 05, 2026 |
| Archive Date: | Oct 11, 2026 |
| Estimated Total Program Funding: | |
| Award Ceiling: | $ |
| Award Floor: | $ |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | (Reissue of PAR-21-266) The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Innovation Research (SBIR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only SBIR Phase II and Fast-Track applications are supported under this program. SBIR Phase I applications are only accepted as part of a Fast-track application. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-23-311.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact: NIH Grants Information
grantsinfo@nih.gov |